SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Definium Therapeutics, Inc. operates as clinical stage biopharmaceutical company, which engages in developing novel product candidates to treat brain health disorders. The company was founded by Stephen L. Hurst, Scott M. Freeman, Leonard Latchman and Jamon Alexander Rahn on July 26, 2010 and is headquartered in New York, NY.

Definium Therapeutics Inc.

Definium Therapeutics is trending due to a major policy catalyst following an executive order signed by President Trump, which aims to accelerate FDA breakthrough therapy reviews for psychedelic-based treatments like psilocybin and MDMA. The community is actively discussing the stock's potential re-rating and its position in the broader mental health innovation sector, with many focused on upcoming Phase 3 trial data as a primary catalyst for future valuation growth.

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Bitcoin is currently experiencing a wave of bullish momentum fueled by speculative reports of Middle East diplomatic progress, triggering a significant short squeeze that has captured the attention of traders. The community remains deeply divided, with bulls aggressively targeting the $80,000 level and calling for a structural breakout, while vocal bears argue the asset is caught in a classic bear trap and remains structurally weak.

Aave is a decentralized money market protocol where users can lend and borrow cryptocurrency across 20 different assets as collateral. The protocol has a native token called AAVE, which is also a governance token that lets the community decide the direction of the protocol in a collective manner. Lenders can&nbsp;earn interest by providing liquidity to the market, while borrowers can borrow by collateralizing their cryptoassets to take out loans from the liquidity pools.

AAVE

AAVE is drawing attention as investors highlight its fundamental strength and consistent revenue generation compared to other DeFi protocols. The community remains focused on long-term accumulation, closely monitoring technical support levels and broader market volatility as traders debate the project's potential for future growth.

Memecoin on Cronos launched by the Cro Crow community

crow with knife

Crow with knife is driving intense community engagement through its multichain presence and deflationary burn mechanism, with supporters actively building a cult-like following. Investors are heavily focused on the project's long-term potential, frequently encouraging others to increase their positions while highlighting the meme's unique brand identity.

Highstreet

Highstreet is seeing intense community debate and speculative trading as users analyze its potential for a short squeeze following a significant pullback from previous highs. Discussions are heavily polarized, with many traders debating the risk of further declines against the potential for a rapid technical reversal based on low supply and oversold indicators.

Cybin, Inc. operates as a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions. It is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. The company was founded by Paul Glavine, Eric So, and John Kanakis on October 13, 2016 and is headquartered in Toronto, Canada.

Helus Pharma Inc.

Helus Pharma is experiencing significant volatility and heightened investor interest as the market reacts to a major rebrand and leadership changes, while simultaneously tracking key clinical catalysts including Phase 2 readouts for its anxiety pipeline and Phase 3 progress for its lead depression program. Community discussions are deeply polarized, with some investors focusing on the company's strong patent portfolio and potential for a sector-wide regulatory re-rating, while others remain skeptical due to historical dilution, poor stock performance, and the company's rebranding efforts.

PolySwarm

PolySwarm is capturing investor attention as the community anticipates a long-awaited breakout, driven by its cybersecurity utility and low market cap. Discussion is currently dominated by bullish sentiment regarding the token's potential for explosive gains, whale accumulation patterns, and hopes for upcoming catalysts that could trigger a significant price reversal.

Compass Pathways Plc is a biotechnology company, which provides mental health care services. It focuses on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. The company was founded by Goldsmith George Jay and Malievskaia Ekaterina in 2016 and is headquartered in London, the United Kingdom.

Compass Pathways Plc - ADR

COMPASS Pathways

COMPASS Pathways is trending following a major executive order that prioritizes the fast-tracking of psychedelic therapies for mental health, fueling community anticipation for potential upcoming clinical trial readouts and regulatory shifts. Investors are actively discussing the stock's position as an industry leader and its pivotal role in the developing psychedelics sector amid broader policy tailwinds.

The Internet Computer is a decentralized cloud blockchain designed to run applications, websites, and backend systems fully on-chain. Its architecture provides robust security, resilience, and built-in multi-chain support.  A key focus of the network is enabling a “self-writing cloud,” where AI tools allow users generate applications through natural-language instructions.  Developers and users can experiment with the platform using AI app-generation tools like caffeine.ai or by writing serverless code directly through online IDEs such as icp.ninja.  The ICP token is used to pay for computation (through a burn-based model) and to participate in network governance through staking.

Internet Computer

Internet Computer (ICP) is attracting significant community attention as users debate its long-term potential as a decentralized cloud infrastructure alternative to Big Tech. While some investors remain skeptical due to past price performance and dilution concerns, proponents are actively promoting its technical milestones like the Caffeine.ai integration and the launch of sovereign subnets as catalysts for future mainstream adoption.

Delcath Systems, Inc. is an oncology company, which engages in the treatment of primary and metastatic liver cancers. Its products include CHEMOSAT and HEPZATO. The company was founded on August 5, 1988 and is headquartered in Queensbury, NY.

Delcath Systems Inc

Delcath Systems is trending due to anticipation surrounding the upcoming CHOPIN trial data, expected in mid-October, which investors hope will validate the platform's clinical value and potentially expand the Hepzato Kit's use as a frontline treatment. While recent revenue guidance and management's explanation of seasonal slowdowns caused significant volatility, the community remains divided, with bulls pointing to growing center activations, strong gross margins, and long-term pipeline potential in additional cancer indications as reasons to accumulate at lower price levels.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

HubSpot, Inc. (NYSE:HUBS) Short Interest Up 18.7% in March

HubSpot, Inc. (NYSE:HUBS - Get Free Report) was the recipient of a large increase in short interest in the month of March. As of March 31st, there was short interest totaling 3,041,358 shares, an increase of 18.7% from the March 15th total of 2,562,507 shares. Based on an average daily volume of...

Slow Capital Inc. Acquires 4,913 Shares of HubSpot, Inc. $HUBS

Slow Capital Inc. raised its holdings in shares of HubSpot, Inc. (NYSE:HUBS - Free Report) by 35.9% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 18,615 shares of the software maker's stock after buying an ad...

HubSpot's (HUBS) Outperform Rating Reaffirmed at Royal Bank Of Canada

Royal Bank Of Canada reaffirmed an "outperform" rating and issued a $400.00 target price on shares of HubSpot in a report on Thursday...

HubSpot (NYSE:HUBS) Downgraded by Zacks Research to Hold

Zacks Research downgraded shares of HubSpot from a "strong-buy" rating to a "hold" rating in a research note on Tuesday...

Here's Why HubSpot (HUBS) is a Strong Growth Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Massachusetts Financial Services Co. MA Raises Stake in HubSpot, Inc. $HUBS

Massachusetts Financial Services Co. MA grew its stake in shares of HubSpot, Inc. (NYSE:HUBS - Free Report) by 67.4% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 146,879 shares of the software maker's stock after purchasing an addit...

Robeco Institutional Asset Management B.V. Trims Stock Position in HubSpot, Inc. $HUBS

Robeco Institutional Asset Management B.V. reduced its stake in shares of HubSpot, Inc. (NYSE:HUBS - Free Report) by 14.0% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 61,034 shares of the software make...

Will HubSpot (HUBS) Beat Estimates Again in Its Next Earnings Report?

HubSpot (HUBS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

These 2 Computer and Technology Stocks Could Beat Earnings: Why They Should Be on Your Radar

Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.

HubSpot vs. AST SpaceMobile: Which Tech Stock Has More Upside?

HUBS is leaning hard into unified customer data and AI across its suite and appears to be a better investment option compared to ASTS.

HubSpot, Inc. engages in cloud-based customer relationship management. Its platform includes marketing, sales, service, operations and content management systems, as well as other tools, integrations, and native payment solutions. The company was founded by Brian Patrick Halligan and Dharmesh Shah on April 4, 2005, and is headquartered in Cambridge, MA.

HUBS
HubSpot Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest HUBS News

HUBSHubSpot Inc